Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Padimate O is an organic small molecule that primarily functions as a UV-B filter in sunscreens and cosmetic products. Chemically known as 2-ethylhexyl 4-(dimethylamino)benzoate, it is a derivative of para-aminobenzoic acid (PABA) that absorbs ultraviolet radiation in the 290-315 nm range, thereby protecting the skin from DNA damage and erythema. Beyond its role in photoprotection, Padimate O is utilized as a chemical penetration enhancer in topical drug delivery systems. It facilitates the transdermal absorption of active pharmaceutical ingredients, such as estradiol and hesperetin, by disrupting the lipid bilayer structure of the stratum corneum. Recent research has also identified its ability to regulate hyaluronan metabolism in human keratinocytes by inhibiting the expression of the hyaluronan-mediated motility receptor (RHAMM).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on padimate o.